BioSpace News Archive

Business

Orexo Q3 2023 Interim Report

The MODIA® study didn’t meet the primary end-points, but showed high rates of treatment response in both study arms, with no adverse events associated with the use of MODIA.

November 2, 2023
·
3 min read
AlzeCure Presents at Redeye Life Science Day on November 23

AlzeCure Pharma AB announced that the company is participating at Redeye Life Science Day 2023 on November 23 at 11:30 CET, where CEO Martin Jönsson will present and answer questions about the latest developments and the company’s plans going forward.

November 2, 2023
·
2 min read
Business

Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Haemonetics Corporation announced that financial results for its second quarter fiscal year 2024, which ended September 30, 2023, are available on its Investor Relations website.

November 2, 2023
·
2 min read
12 Posters and Presentations Featuring MolecuLight to be Presented at the SAWC Fall 2023 Conference

MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of elevated bacterial loads in wounds, announces that MolecuLight data will be presented in 12 clinical posters and presentations at the Symposium on Advanced Wound Care Fall 2023.

November 2, 2023
·
7 min read
Business

Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results

Aurinia Pharmaceuticals Inc. issued its financial results for the three and nine months ended September 30, 2023. Amounts are expressed in U.S. dollars.

November 2, 2023
·
19 min read
Business

SpringWorks Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

SpringWorks Therapeutics, Inc. reported third quarter financial results for the period ended September 30, 2023 and provided an update on recent business highlights.

November 2, 2023
·
13 min read
Business

The Cigna Group Reports Strong Third Quarter 2023 Results, Raises 2023 Adjusted EPS, Revenue, and Cash Flow Outlook

Global health company The Cigna Group reported strong third quarter results reflecting revenue and earnings growth across its diversified portfolio of businesses.

November 2, 2023
·
27 min read
BioMidwest

Genezen Secures $18.5 Million in Growth Equity to Expand Viral Vector Development and Manufacturing Capabilities

Genezen, a leading cell and gene therapy Contract Development and Manufacturing Organization, announced the closing of an $18.5 million follow-on growth equity investment led by Ampersand Capital Partners.

November 2, 2023
·
3 min read
Drug Development

Memo Therapeutics AG Raises CHF 25 Million Series C Financing to Complete Phase II Clinical Development of AntiBKV for BKV Infection in Renal Transplant Patients

Memo Therapeutics AG, a late-stage biotech company developing best-in-class therapeutic antibodies, announced the closing of a CHF25 million Series C financing led by Pureos Bioventures.

November 2, 2023
·
3 min read
Business

Constructive Bio Strengthens Management Team and Board of Directors with Key Appointments to Accelerate Synthetic Genomics to Innovate Biologic Therapies

Constructive Bio, a biotech that rewrites genomes to create biomolecules that were previously unimaginable, announces the appointment of Dr Paul Wallace as Chief Business Officer, and Rahul K Dhanda as a Non-Executive Director with immediate effect.

November 2, 2023
·
4 min read